Welcome to our state-of-the-art m1A-MAP-seq service, designed to propel your RNA epigenetics research from regional estimates to absolute single-nucleotide certainty. By leveraging advanced AlkB demethylase treatment, we offer a robust "turnkey" solution for mapping N1-methyladenosine modifications. Our service is engineered to overcome the historical bottlenecks of traditional antibody-based screening, empowering your complex mechanistic studies with top-tier, verifiable, and publication-ready data.
Core Service Advantages:
True Single-Base Precision: Exact nucleotide mapping via misincorporation-assisted profiling.
Rigorous False-Positive Control: Mandatory Demethylase (+/-) and Input parallel sequencing.
Comprehensive RNA Coverage: Robust detection across mRNA, tRNA, rRNA, and non-coding RNAs.
Complex Sample Handling: Proven track record with low-yield tissues and non-model organism extractions.
N1-methyladenosine (m1A) is a highly dynamic and critical RNA modification that fundamentally alters the physicochemical properties of RNA. Because the methyl group at the N1 position of adenine adds a positive charge and disrupts normal Watson-Crick base pairing, m1A dramatically impacts RNA structural stability, protein-RNA interactions, and translation efficiency. While m1A is abundant and relatively stable in tRNA and rRNA, its presence in mRNA and non-coding RNAs is often transient, lowly abundant, and highly context-dependent, making accurate detection a persistent challenge in epigenetics.
Traditional antibody-based screening methods often lack the precise resolution required for deep mechanistic studies, typically yielding peaks that span 100 to 200 nucleotides. This regional data is insufficient when researchers need to perform targeted functional validations, such as designing specific guide RNAs for CRISPR editing.
Our m1A-MAP-seq service overcomes this limitation by utilizing an advanced AlkB demethylase treatment paired with a misincorporation-assisted profiling strategy. During standard reverse transcription, the bulky m1A modification causes the reverse transcriptase enzyme to stall or introduce mutations (mismatches). By systematically treating a parallel RNA aliquot with the wild-type E. coli AlkB demethylase—which efficiently removes the m1A methyl group—we can compare the sequencing read mismatch rates between treated and untreated samples. By capturing these precise reverse transcription misincorporations induced by m1A, we deliver true single-base resolution data.
This unparalleled precision empowers researchers utilizing broad RNA Methylation Services to transition seamlessly into exact nucleotide validation.
Applications
Key Applications in RNA Epigenetics Research
Mapping m1A at a single-nucleotide level opens new avenues for understanding complex biological systems. Our service is tailored to support a wide range of advanced research applications, ensuring your data directly translates to biological insights:
Disease Mechanism Elucidation
Aberrant m1A methylation is heavily implicated in various pathologies, including metabolic syndromes and tumorigenesis. By pinpointing the exact location of m1A sites on critical oncogenes or tumor suppressor transcripts, researchers can map out the precise regulatory networks driving disease progression. This allows for the identification of specific reader, writer, and eraser proteins that may serve as novel downstream functional targets.
Translational Regulation & Ribosome Dynamics
Because m1A disrupts base pairing, its presence in the 5' UTR or CDS of mRNA can create structural roadblocks or alter start codon recognition, fundamentally shifting translation efficiency. Furthermore, m1A at position 58 of eukaryotic initiator tRNA is essential for maintaining initiator tRNA stability. Single-base mapping allows researchers to correlate specific methylation events with polysome profiling data to understand exactly how translation is modulated under cellular stress.
Targeted Mutagenesis Guidance
When transitioning from bioinformatics to in vitro or in vivo models, researchers need exact genomic coordinates. Regional m1A peaks make it impossible to know which specific adenine to mutate. Our m1A-MAP-seq data provides the exact single-base coordinates required to design precise CRISPR/Cas9 or base-editing experiments, allowing you to validate the physiological impact of individual m1A sites with absolute confidence.
High-Resolution Biomarker Discovery
For translational research, global methylation levels often lack the specificity needed for precise molecular profiling. Identifying unique, single-nucleotide epigenetic signatures—such as a specific m1A modification on a circulating non-coding RNA—offers a much more precise indicator for mapping disease pathways and molecular phenotyping.
Decision Guide
m1A-MAP-seq vs. m1A-MeRIP-seq: A Strategic Guide
Selecting the right sequencing technology is crucial for optimizing your research budget and achieving publication goals. The choice between immunoprecipitation and misincorporation profiling should be dictated by the current phase of your research. We highly recommend a "Screen & Validate" strategy:
Global Screening: Utilize the m1A-MeRIP-seq Service for initial broad profiling across large sample cohorts. This is the most cost-effective way to identify general areas of differential methylation between wild-type and disease models.
Targeted Validation: Transition to m1A-MAP-seq to confirm specific functional target sites and resolve the precise nucleotide position before commencing with complex mechanistic modeling.
Feature
m1A-MeRIP-seq
m1A-MAP-seq
Resolution
Regional peak (~100-200 nt)
True single-nucleotide precision
Mechanism
Antibody-based IP enrichment
AlkB demethylation + RT misincorporation
Primary Goal
Global transcriptomic screening & discovery
Precise site validation & functional mechanism
False Positive Rate
Moderate (antibody cross-reactivity)
Extremely low (strict internal controls)
Input Volume
Standard
Generally higher input required due to multi-arm prep
Workflow
Rigorous Workflow & Demethylase-Controlled QC
A major challenge in single-base mapping is differentiating genuine m1A misincorporations from natural single nucleotide polymorphisms (SNPs) or reverse transcriptase background errors. Our optimized workflow integrates a mandatory, strictly controlled experimental design to virtually eliminate false positives.
RNA Fragmentation & Primary Enrichment: Total RNA is carefully fragmented to ~150nt to ensure optimal sequencing coverage. The fragments are first enriched using a highly specific anti-m1A antibody. Crucially, an untreated portion of the total RNA is retained as the Input control to map baseline expression levels and genomic SNPs.
Enzymatic Branching (The Critical QC Step): The antibody-enriched fragments are divided into two parallel, strictly controlled reactions:
Demethylase (+): Treated with AlkB demethylase (an alpha-ketoglutarate and iron-dependent dioxygenase) to efficiently erase the m1A marks, allowing the reverse transcriptase to read through normally, substituting standard adenine.
Demethylase (-): Left untreated, forcing the reverse transcriptase to stall or misincorporate (typically inserting a complementary thymine, cytosine, or guanine instead of the expected thymine) at the exact site of the m1A modification.
Library Preparation & High-Depth Sequencing: Specialized adapter ligation and reverse transcription protocols are used to capture highly structured RNAs (like tRNAs) without bias. The libraries undergo high-depth Illumina sequencing.
Bioinformatic Misincorporation Calling: By directly comparing the mismatch rates at specific adenine loci between the Demethylase (+) and Demethylase (-) libraries during bioinformatic alignment, we isolate true m1A-induced mutation signals with absolute statistical confidence, filtering out any background enzymatic noise.
Bioinformatics
Publication-Ready Bioinformatics Deliverables
Our expert bioinformatics team bridges the gap between raw sequencing data and high-impact publications. We do not just provide raw fastq files; we deliver a comprehensive suite of analytical data tailored for deep mechanistic parsing.
Minimum Deliverables:
Comprehensive Raw Data Quality Control (FastQC) and adapter trimming.
High-fidelity read alignment to the reference genome utilizing mismatch-tolerant algorithms.
Demethylase-controlled misincorporation site calling and statistical error rate quantification.
Single-base m1A annotation across the entire transcriptome.
Optional Advanced Add-ons for Mechanistic Insight:
m1A Peak Distribution Analysis: Visualizing methylation density across distinct transcript architectures.
m1A Motif Analysis: Generating sequence logos to identify consensus motifs surrounding the exact methylation sites.
Functional Enrichment: Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway mapping.
Demo Results
Publication-Ready Demo Results
Our expert bioinformatics pipeline translates complex single-base mapping data into high-impact, publication-ready visualizations. Below are representative deliverables from our m1A-MAP-seq analysis framework combined into a single view:
m1A Peak Density Distribution: Visualizes the accumulation of m1A modifications across different transcript segments (5'UTR, CDS, 3'UTR). This helps identify regional methylation preferences and broad transcriptomic architectures affected by the epigenetic mark.
Differential Methylation Clustering: A hierarchical heatmap analysis that clusters distinct m1A sites between control and treated/mutant samples. This instantly highlights systemic epigenetic shifts and clearly separates biological replicates based on their modification profiles.
m1A Motif Analysis: Extracts and visualizes consensus sequence logos (e.g., GGACA) surrounding the exact methylation sites. Pinpointing the sequence environment is critical for predicting specific methyltransferase or reader protein binding preferences.
m1A Site Visualization Tracks: Genome browser tracks directly comparing Input and m1A IP signals (alongside the critical demethylase +/- libraries). This track visualization validates precise single-nucleotide misincorporation events and enrichment at targeted gene loci.
GO and KEGG Pathway Enrichment: Maps heavily modified transcripts to their functional Gene Ontology terms and KEGG pathways, connecting molecular-level epigenetic changes to broad biological phenotypes and signal transduction pathways.
Sample Requirements
Sample Requirements
We recognize that advanced epigenetic studies often rely on precious, hard-to-obtain samples. We have extensive experience processing challenging materials, including low-yield preclinical tissues, complex non-model organisms, and highly degraded samples. If your laboratory struggles with primary RNA isolation, we highly recommend utilizing our Complex Sample RNA Extraction capabilities to ensure maximum yield and purity before sequencing begins.
All samples must be shipped in 1.5 mL centrifuge tubes, securely sealed with parafilm, and transported on dry ice to ensure complete RNA integrity.
Sample Type
Required Amount
Shipping
Storage & Preparation Notes
Cell Cultures
≥ 2 × 10^7 cells
Dry Ice
Snap-freeze in liquid nitrogen, store at -80°C. Avoid repeated freeze-thaw cycles.
Fresh Tissues
100 mg – 1 g
Dry Ice
Cut into small pieces (5-10 mg), snap-freeze in liquid nitrogen, store at -80°C.
Total RNA
30 – 300 μg
Dry Ice
Dissolve in ethanol or RNase-free H2O, store at -80°C. Strict QC: OD260/280 ≥ 1.8; OD260/230 ≥ 1.5; RIN ≥ 7 (or 28S:18S ≥ 1.5); intact bands without obvious degradation.
Body Fluids & Others
Please inquire
Dry Ice
Contact our technical team for specific preclinical collection protocols.
Case Study
Case Study: N1-Methyladenosine Methylation in tRNA Drives Liver Tumourigenesis
Compliance / Disclaimer / Research Use Only The services, technologies, and data provided herein are strictly for Research Use Only (RUO). They are not intended, validated, or approved for use in diagnostic procedures, clinical decision-making, or therapeutic applications.
